Global Remicade (infliximab) Drug Market Professional Survey Report 2019

Published Date : 2019-10-08

Published By : Qy Research

Category : Pharma & Healthcare

No. of Pages : 102

Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases.

The global Remicade (infliximab) Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Remicade (infliximab) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Remicade (infliximab) Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Remicade (infliximab) Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Remicade (infliximab) Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Janssen
Hospira
Celltrion Healthcare
Epirus Biopharmaceuticals
Samsung Bioepsis
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Brands Drugs
Generic Drugs

Segment by Application
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other

Table of Contents

Executive Summary
1 Industry Overview of Remicade (infliximab) Drug
1.1 Definition of Remicade (infliximab) Drug
1.2 Remicade (infliximab) Drug Segment by Type
1.2.1 Global Remicade (infliximab) Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Remicade (infliximab) Drug Segment by Applications
1.3.1 Global Remicade (infliximab) Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Pediatric Ulcerative Colitis
1.3.6 Other
1.4 Global Remicade (infliximab) Drug Overall Market
1.4.1 Global Remicade (infliximab) Drug Revenue (2014-2025)
1.4.2 Global Remicade (infliximab) Drug Production (2014-2025)
1.4.3 North America Remicade (infliximab) Drug Status and Prospect (2014-2025)
1.4.4 Europe Remicade (infliximab) Drug Status and Prospect (2014-2025)
1.4.5 China Remicade (infliximab) Drug Status and Prospect (2014-2025)
1.4.6 Japan Remicade (infliximab) Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Remicade (infliximab) Drug Status and Prospect (2014-2025)
1.4.8 India Remicade (infliximab) Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Remicade (infliximab) Drug
2.3 Manufacturing Process Analysis of Remicade (infliximab) Drug
2.4 Industry Chain Structure of Remicade (infliximab) Drug

3 Development and Manufacturing Plants Analysis of Remicade (infliximab) Drug
3.1 Capacity and Commercial Production Date
3.2 Global Remicade (infliximab) Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Remicade (infliximab) Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Remicade (infliximab) Drug Production and Capacity Analysis
4.2 Remicade (infliximab) Drug Revenue Analysis
4.3 Remicade (infliximab) Drug Price Analysis
4.4 Market Concentration Degree

5 Remicade (infliximab) Drug Regional Market Analysis
5.1 Remicade (infliximab) Drug Production by Regions
5.1.1 Global Remicade (infliximab) Drug Production by Regions
5.1.2 Global Remicade (infliximab) Drug Revenue by Regions
5.2 Remicade (infliximab) Drug Consumption by Regions
5.3 North America Remicade (infliximab) Drug Market Analysis
5.3.1 North America Remicade (infliximab) Drug Production
5.3.2 North America Remicade (infliximab) Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Remicade (infliximab) Drug Import and Export
5.4 Europe Remicade (infliximab) Drug Market Analysis
5.4.1 Europe Remicade (infliximab) Drug Production
5.4.2 Europe Remicade (infliximab) Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Remicade (infliximab) Drug Import and Export
5.5 China Remicade (infliximab) Drug Market Analysis
5.5.1 China Remicade (infliximab) Drug Production
5.5.2 China Remicade (infliximab) Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Remicade (infliximab) Drug Import and Export
5.6 Japan Remicade (infliximab) Drug Market Analysis
5.6.1 Japan Remicade (infliximab) Drug Production
5.6.2 Japan Remicade (infliximab) Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Remicade (infliximab) Drug Import and Export
5.7 Southeast Asia Remicade (infliximab) Drug Market Analysis
5.7.1 Southeast Asia Remicade (infliximab) Drug Production
5.7.2 Southeast Asia Remicade (infliximab) Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Remicade (infliximab) Drug Import and Export
5.8 India Remicade (infliximab) Drug Market Analysis
5.8.1 India Remicade (infliximab) Drug Production
5.8.2 India Remicade (infliximab) Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Remicade (infliximab) Drug Import and Export

6 Remicade (infliximab) Drug Segment Market Analysis (by Type)
6.1 Global Remicade (infliximab) Drug Production by Type
6.2 Global Remicade (infliximab) Drug Revenue by Type
6.3 Remicade (infliximab) Drug Price by Type

7 Remicade (infliximab) Drug Segment Market Analysis (by Application)
7.1 Global Remicade (infliximab) Drug Consumption by Application
7.2 Global Remicade (infliximab) Drug Consumption Market Share by Application (2014-2019)

8 Remicade (infliximab) Drug Major Manufacturers Analysis
8.1 Janssen
8.1.1 Janssen Remicade (infliximab) Drug Production Sites and Area Served
8.1.2 Janssen Product Introduction, Application and Specification
8.1.3 Janssen Remicade (infliximab) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Hospira
8.2.1 Hospira Remicade (infliximab) Drug Production Sites and Area Served
8.2.2 Hospira Product Introduction, Application and Specification
8.2.3 Hospira Remicade (infliximab) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Celltrion Healthcare
8.3.1 Celltrion Healthcare Remicade (infliximab) Drug Production Sites and Area Served
8.3.2 Celltrion Healthcare Product Introduction, Application and Specification
8.3.3 Celltrion Healthcare Remicade (infliximab) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Epirus Biopharmaceuticals
8.4.1 Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Sites and Area Served
8.4.2 Epirus Biopharmaceuticals Product Introduction, Application and Specification
8.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Samsung Bioepsis
8.5.1 Samsung Bioepsis Remicade (infliximab) Drug Production Sites and Area Served
8.5.2 Samsung Bioepsis Product Introduction, Application and Specification
8.5.3 Samsung Bioepsis Remicade (infliximab) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Remicade (infliximab) Drug Market
9.1 Global Remicade (infliximab) Drug Market Trend Analysis
9.1.1 Global Remicade (infliximab) Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Remicade (infliximab) Drug Regional Market Trend
9.2.1 North America Remicade (infliximab) Drug Forecast 2019-2025
9.2.2 Europe Remicade (infliximab) Drug Forecast 2019-2025
9.2.3 China Remicade (infliximab) Drug Forecast 2019-2025
9.2.4 Japan Remicade (infliximab) Drug Forecast 2019-2025
9.2.5 Southeast Asia Remicade (infliximab) Drug Forecast 2019-2025
9.2.6 India Remicade (infliximab) Drug Forecast 2019-2025
9.3 Remicade (infliximab) Drug Market Trend (Product Type)
9.4 Remicade (infliximab) Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Remicade (infliximab) Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer


List of Tables and Figures
Figure Picture of Remicade (infliximab) Drug
Table Global Remicade (infliximab) Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Remicade (infliximab) Drug Production Market Share by Types in 2018
Figure Brands Drugs Product Picture
Figure Generic Drugs Product Picture
Table Global Remicade (infliximab) Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Remicade (infliximab) Drug Consumption Market Share by Applications in 2018
Figure Crohn's Disease
Figure Pediatric Crohn's Disease
Figure Ulcerative Colitis
Figure Pediatric Ulcerative Colitis
Figure Other
Figure Global Remicade (infliximab) Drug Revenue (Million USD) (2014-2025)
Figure Global Remicade (infliximab) Drug Production (K Units) (2014-2025)
Figure North America Remicade (infliximab) Drug Market Size (Million USD) (2014-2025)
Figure Europe Remicade (infliximab) Drug Market Size (Million USD) (2014-2025)
Figure China Remicade (infliximab) Drug Market Size (Million USD) (2014-2025)
Figure Japan Remicade (infliximab) Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Remicade (infliximab) Drug Market Size (Million USD) (2014-2025)
Figure India Remicade (infliximab) Drug Market Size (Million USD) (2014-2025)
Table Remicade (infliximab) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Remicade (infliximab) Drug in 2018
Figure Manufacturing Process Analysis of Remicade (infliximab) Drug
Figure Industry Chain Structure of Remicade (infliximab) Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Remicade (infliximab) Drug Manufacturing Plants Distribution
Table Remicade (infliximab) Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Remicade (infliximab) Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Remicade (infliximab) Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Remicade (infliximab) Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Remicade (infliximab) Drug Production Share by Manufacturers in 2018
Table Remicade (infliximab) Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Remicade (infliximab) Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Remicade (infliximab) Drug Revenue Share by Manufacturers in 2018
Table Remicade (infliximab) Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Remicade (infliximab) Drug Production by Regions 2014-2019 (K Units)
Table Global Remicade (infliximab) Drug Production Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Production Market Share by Regions in 2018
Table Global Remicade (infliximab) Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Remicade (infliximab) Drug Revenue Market Share by Regions 2014-2019
Figure Global Remicade (infliximab) Drug Revenue Market Share by Regions in 2018
Table Global Remicade (infliximab) Drug Consumption by Regions 2014-2019 (K Units)
Table Global Remicade (infliximab) Drug Consumption Market Share by Regions 2014-2019
Figure North America Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Remicade (infliximab) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Remicade (infliximab) Drug Production, Consumption Import and Export (K Units)
Figure Europe Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Remicade (infliximab) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Remicade (infliximab) Drug Production, Consumption Import and Export (K Units)
Figure China Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure China Remicade (infliximab) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Remicade (infliximab) Drug Production, Consumption Import and Export (K Units)
Figure Japan Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Remicade (infliximab) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Remicade (infliximab) Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Remicade (infliximab) Drug Production, Consumption Import and Export (K Units)
Figure India Remicade (infliximab) Drug Production Growth Rate 2014-2019 (K Units)
Figure India Remicade (infliximab) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Remicade (infliximab) Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Remicade (infliximab) Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Remicade (infliximab) Drug Market Share by Application (2014-2019)
Table Janssen Remicade (infliximab) Drug Production Sites and Area Served
Table Janssen Remicade (infliximab) Drug Product Introduction, Application and Specification
Table Janssen Remicade (infliximab) Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Janssen Remicade (infliximab) Drug Production Market Share (2014-2019)
Figure Janssen Remicade (infliximab) Drug Revenue Market Share (2014-2019)
Table Janssen Remicade (infliximab) Drug Main Business and Markets Served
Table Hospira Remicade (infliximab) Drug Production Sites and Area Served
Table Hospira Remicade (infliximab) Drug Product Introduction, Application and Specification
Table Hospira Remicade (infliximab) Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hospira Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Hospira Remicade (infliximab) Drug Production Market Share (2014-2019)
Figure Hospira Remicade (infliximab) Drug Revenue Market Share (2014-2019)
Table Hospira Remicade (infliximab) Drug Main Business and Markets Served
Table Celltrion Healthcare Remicade (infliximab) Drug Production Sites and Area Served
Table Celltrion Healthcare Remicade (infliximab) Drug Product Introduction, Application and Specification
Table Celltrion Healthcare Remicade (infliximab) Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion Healthcare Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Celltrion Healthcare Remicade (infliximab) Drug Production Market Share (2014-2019)
Figure Celltrion Healthcare Remicade (infliximab) Drug Revenue Market Share (2014-2019)
Table Celltrion Healthcare Remicade (infliximab) Drug Main Business and Markets Served
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Sites and Area Served
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Introduction, Application and Specification
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Production Market Share (2014-2019)
Figure Epirus Biopharmaceuticals Remicade (infliximab) Drug Revenue Market Share (2014-2019)
Table Epirus Biopharmaceuticals Remicade (infliximab) Drug Main Business and Markets Served
Table Samsung Bioepsis Remicade (infliximab) Drug Production Sites and Area Served
Table Samsung Bioepsis Remicade (infliximab) Drug Product Introduction, Application and Specification
Table Samsung Bioepsis Remicade (infliximab) Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Samsung Bioepsis Remicade (infliximab) Drug Production Growth Rate (2014-2019)
Table Samsung Bioepsis Remicade (infliximab) Drug Production Market Share (2014-2019)
Figure Samsung Bioepsis Remicade (infliximab) Drug Revenue Market Share (2014-2019)
Table Samsung Bioepsis Remicade (infliximab) Drug Main Business and Markets Served
Figure Global Remicade (infliximab) Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Remicade (infliximab) Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Remicade (infliximab) Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Remicade (infliximab) Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Remicade (infliximab) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Remicade (infliximab) Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Remicade (infliximab) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Remicade (infliximab) Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Remicade (infliximab) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Remicade (infliximab) Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Remicade (infliximab) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Remicade (infliximab) Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Remicade (infliximab) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Remicade (infliximab) Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Remicade (infliximab) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Remicade (infliximab) Drug by Type (2019-2025)
Table Global Consumption (K Units) of Remicade (infliximab) Drug by Application (2019-2025)
Table Remicade (infliximab) Drug Distributors List
Table Remicade (infliximab) Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Remicade (infliximab) Drug  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com